Near-circumferential lower body lift: a review of 40 outpatient procedures
Pay particular attention to IGF-1 levels (which should rise with Tesamorelin but stay within a healthy reference range), fasting glucose and insulin (to monitor for any GH-related insulin resistance), liver enzymes (both compounds have liver-protective effects, but monitoring confirms this), and lipid panels (you should see improvements in triglycerides and LDL)
You may notice: earlier fullness reduced interest in food steadier energy You may not see weight change yet, but these early signals mean its working
Methods PubMed, Cochrane, Web of Science and Embase were searched for randomized placebo-controlled trials with SGLT-2i or GLP-1 RAs as interventions of type 2 diabetes patients up to June, 2024
Reduces Cognitive Decline: May reduce the risk of age-related cognitive decline and dysfunction
Higher doses (12.5-15 mg weekly) cost more than starter doses